Early bird registration is open and closes May 2025. Register now

Abstracts deadline EXTENDED Friday 22 May 2026! Submit now

d
h
m
s

Chugai Pharmaceutical/ JW Pharmaceuticals

Co-sponsors

Chugai Pharmaceuticals

Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai is committed to creating innovative pharmaceutical products that may satisfy unmet medical needs. Chugai is listed on the Prime Market of the Tokyo Stock Exchange. While maintaining autonomy and management independence, Chugai is an important member of the Roche Group.

Taking a technology-driven approach unconstrained by therapeutic area, Chugai has been continuously building unique drug-discovery platforms employing multiple modalities and proprietary technologies to pursue transformative drugs for patients.

Additional information is available at: https://www.chugai-pharm.co.jp/english/innovation/

JW Pharmaceuticals

JW Pharmaceutical CORPORATION, who has been leading hospital market with its medical products in Korea, is strengthening its global competitiveness by getting the outstanding pipeline for original medicine and medical supplies and putting its passion to develop innovative new medicine through its global R&D network.

Share

Key dates

Registrations
Abstracts

More Partners / Exhibitors

medac GmbH

Medac GmbH

Takeda

GSK

Novartis

Chugai Pharmaceutical/ JW Pharmaceuticals

SK Chemicals

Days
Hours
Minutes
Seconds
Until 11:59PM AEST Friday 24 April, 2026

The countdown is on

Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.